|
Vol.
27 No. 3
May-June 2005
IUPAC
Wire |
|
|
News
and information on IUPAC, its fellows, and members organizations
See also www.iupac.org/news |
Subcommittee
Members Teach Short Course on Medicinal Chemistry
|
Three
IUPAC members with a group of Brazilian postgraduate
students during the summer school: 3rd from the left,
Janos Fischer; 5th: Eliezer J. Barreiro; and 6th: Eli
Breuer.
|
The
Subcommittee
on Medicinal Chemistry and Drug Development of the IUPAC
Chemistry and Human Health Division (Div VII) held its
last meeting in Rio de Janeiro, Brazil, to coincide with the
XI Summer School in Pharmaceutical and Medicinal Chemistry
at the Laboratory of the Federal University of Rio de Janeiro.
About 200 students participated in the Summer School, organized
by Professor Eliezer J. Barreiro. Within the framework of
this Summer School, the subcommittee members taught a short
course (a total of 11 hours) entitled “Highlights in
Medicinal Chemistry” in which about 40 postgraduate
students and postdoctoral researchers participated. The subcommittee
met all day on 13 February, while the course went from 14
to 18 February 2005.
The
short course was special because most of the lecturers are
also inventors of drugs, so they provided real insight into
the process of new drug discovery. The caliber of lecturers,
the excellent organization of Prof. Barreiro, and the interest
of the students created a good atmosphere. The subcommittee
was very satisfied with the weeklong format and schedule and
agreed that such events will spark interest in IUPAC among
young scientists.
Highlights
in Medicinal Chemistry - short course program
Session 1
Past Approaches to Drug Discovery - an historical survey,
Prof. Robin Ganellin (RG, University College London, UK)
Drug Discovery in Traditional Medicine, Dr. Mukund
Chorghade (MC, Chorghade Enterprises, USA)
Design and Discovery of Viramune - a Marketed anti-AIDS
Drug, Dr. John Proudfoot (JP, Boehringer-Ingelheim,
USA)
Session
2
Current AIDS Therapeutics - examples of Modern Drug Discovery
at Work, JP
Process Chemistry, MC
Session
3
Design of a Peptidase Inhibitor, RG
Session
4
Medicinal Chemistry of Antiulcer Agents, Dr. Jörg
Senn-Bilfinger (Altana Pharma, Germany)
Esmolol -the birth of soft drug technology- and Beyond,
Prof. Paul W. Erhardt (PWE, University of Toledo, USA)
Drug Metabolism and Drug Design, PWE
Session
5
Analog-based Drug Discovery (an
IUPAC project), Dr. Janos Fischer (Richter Ltd, Hungary)
Matrix Metalloproteinases (MMPs): Their Damage and the
Effort for their Inhibition, Prof. Eli Breuer (Hebrew
University Jerusalem)
For
more information contact Robin
Ganellin <[email protected]>,
chairman of the Subcommittee on Medicinal Chemistry and
Drug Development.
www.iupac.org/divisions/VII/VII.M
Page
last modified 21 April 2005.
Copyright © 2003-2005 International Union of Pure and
Applied Chemistry.
Questions regarding the website, please contact [email protected]
|